CD36, a multi-ligand scavenger receptor expressed on the surface of platelets, adipocytes, hepatocytes, and epithelial cells, was reported to be associated with adverse prognosis and treatment resistance of patients with GC and other solid tumors [23–27]. The gene discussed is CD36; the disease is gastric cancer.